Still a reasonable goal: Targeting cholesterol in dialysis and advanced chronic kidney disease patients.

Heine, Gunnar H; Rogacev, Kyrill S; Weingärtner, Oliver; Marsche, Gunther

Heine, Gunnar H; Rogacev, Kyrill S; Weingärtner, Oliver; Marsche, Gunther.

Affiliation

Heine GH; Saarland University Medical Center, Homburg, Germany.
Rogacev KS; University Heart Center Luebeck, Medical Clinic II (Cardiology/Angiology/Intensive Care Medicine), University Hospital Schleswig-Holstein, Luebeck, Germany.
Weingärtner O; Department of Cardiology, University Hospital Oldenburg, European Medical School Oldenburg-Groningen, Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany.
Marsche G; Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria.

Semin Dial ; 30(5): 390-394, 2017 09.

Article in En | MEDLINE | ID: mdl-28628255

Subject(s)

Cholesterol/blood; Dyslipidemias/drug therapy; Hypolipidemic Agents/therapeutic use; Renal Dialysis/adverse effects; Renal Insufficiency, Chronic/complications; Cardiovascular Diseases/etiology; Dyslipidemias/etiology; Humans; Renal Insufficiency, Chronic/therapy; Risk Factors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Cholesterol / Renal Dialysis / Renal Insufficiency, Chronic / Dyslipidemias / Hypolipidemic Agents Type of study: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Semin Dial Journal subject: NEFROLOGIA Year: 2017 Type: Article Affiliation country: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google